Trial Profile
Relative Bioavailability of Dabigatran and Diclofenac After 150 mg b.i.d. Dabigatran Etexilate and Diclofenac at 50 mg Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers (an Open Label, Randomised, Multiple- Dose, Three-way Crossover Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2014
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Diclofenac (Primary)
- Indications Embolism and thrombosis
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 05 Nov 2010 New trial record.